CABA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Autoimmune Pipeline PCVX Q1 2026 Earnings Missed Estimates Amid PreRevenue Stage Stock Inches Higher BATL Q2 2023 Earnings NarrowerThanExpected Loss Fails to Lift Shares PBYI Q1 2026 Earnings EPS Surprise of 4721 as Narrowed Loss Beats Estimates ThredUp TDUP Q1 2026 Earnings Narrow Loss Beats Estimates but Stock Slips on Revenue Concerns Immunome Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Declines